GOSH Podcast

Gynecologic Cancer Initiative
  • 0.0 (0)
  • MEDICINE
  • UPDATED MONTHLY

Presented by the Gynecologic Cancer Initiative, the Gynecologic Oncology Sharing Hub (GOSH) is an open space for real and evidence-based discussions on gynecologic cancers. We share stories of lived experiences alongside research and clinical discoveries through conversations that turn insights into impact.

  1. 6D AGO

    From Idea to Impact: The Story of the Canadian Conference on Ovarian Cancer Research

    In recognition of Cancer Research Month 💜🎗️, we sit down with Dr. Barbara Vanderhyden to reflect on the origins and evolution of the Canadian Conference on Ovarian Cancer Research (CCOCR). What began as a small, ambitious idea in 2001 has grown into a national, multidisciplinary forum bringing together basic scientists, clinicians, epidemiologists, and psychosocial researchers from across Canada. In this episode, we discuss the importance of collaboration in advancing ovarian cancer research, the role of trainees within this community, and how CCOCR continues to shape research, partnerships, and progress nationwide. We also look ahead to this year’s conference at UBC and what attendees—especially trainees—can expect to take away. Resources: https://ovariancanada.org/events/canadian-conference-on-ovarian-cancer-research?gad_source=1&gad_campaignid=23711798144&gbraid=0AAAAADsQjwFfTQHlk_3CNNNXiFv76oiL3&gclid=CjwKCAjw46HPBhAMEiwASZpLRDt6xWhR4LtqEnxWsonv3joiqBGxaEAM78_hbI5MCEBrPwI1WTQoABoCmT8QAvD_BwE  For more information on the Gynecologic Cancer Initiative, please visit https://gynecancerinitiative.ca/ or email us at info@gynecancerinitiative.ca  Where to learn more about us:   Twitter – @GCI_Cluster  Instagram – @gynecancerinitiative  Facebook – facebook.com/gynecancerinitiative TikTok – @gci_gosh

    25 min

  2. APR 13

    Next Gen in 10: Rethinking Endometrial Cancer Surveillance in Lynch Syndrome

    🎙️ Next Gen in 10 is back! This episode features Arabella Helgason, a UBC Master’s student supervised by Dr. Aline Talhouk, whose research examines how endometrial cancer surveillance currently works for Lynch syndrome carriers — and how it might be improved. Using population data, Arabella is exploring surveillance patterns and investigating new approaches, including the potential role of self-sampling.  🎧 Tune in to learn how trainee research is helping rethink cancer surveillance. For more information on the Gynecologic Cancer Initiative, please visit https://gynecancerinitiative.ca/ or email us at info@gynecancerinitiative.ca  Where to learn more about us:   Twitter – @GCI_Cluster  Instagram – @gynecancerinitiative  Facebook – facebook.com/gynecancerinitiative TikTok – @gci_gosh

    25 min

  3. APR 1

    From Prediction to Prevention: Rethinking Endometrial Cancer Risk

    New episode alert! 🎙️ How can we move beyond BMI to better understand endometrial cancer risk? In this episode, Dr. Aline Talhouk and Dr. Andrea Neilson discuss the RESTORE study and the use of the Progesterone Challenge Test (PCT) as a functional way to assess hormonal activity in the endometrium — and identify who may truly be at higher biological risk. We talk through the study design, as well as early findings showing strong feasibility and participant engagement. The conversation also explores how this approach could support more targeted prevention strategies moving forward. 🎧 Listen now! For more information on the Gynecologic Cancer Initiative, please visit https://gynecancerinitiative.ca/ or email us at info@gynecancerinitiative.ca  Where to learn more about us:   Twitter – @GCI_Cluster  Instagram – @gynecancerinitiative  Facebook – facebook.com/gynecancerinitiative TikTok – @gci_gosh

    25 min

  4. MAR 16

    Next Gen in 10: The Endometriosis Pain Index and the Future of Surgical Care

    Can we better predict who will benefit from endometriosis surgery? In this episode, Sabrina speaks with Dr. Dwayne Tucker about developing the Endometriosis Pain Index — a machine learning–based tool designed to help guide surgical decision-making and set realistic expectations for pain outcomes. From predictive modelling to patient-centred care, this conversation explores how data can transform how we approach endometriosis treatment. 🎧 Listen now wherever you get your podcasts. #Endometriosis #WomensHealth #SurgicalCare #HealthResearch #NextGenIn10 Resources Endometriosis pain index: development of a model to predict poor pain-related quality of life after endometriosis surgery through machine learning analysis of registry data https://journals.lww.com/pain/fulltext/9900/endometriosis_pain_index__development_of_a_model.1125.aspx Pelvic pain comorbidities associated with quality of life after endometriosis surgery https://pubmed.ncbi.nlm.nih.gov/37148956/ Somatic PTEN and ARID1A loss and endometriosis disease burden: a longitudinal study https://pubmed.ncbi.nlm.nih.gov/39701665/ Assessing the Utility of artificial intelligence in endometriosis: Promises and pitfalls https://pubmed.ncbi.nlm.nih.gov/38686828/ For more information on the Gynecologic Cancer Initiative, please visit https://gynecancerinitiative.ca/ or email us at info@gynecancerinitiative.ca  Where to learn more about us:   Twitter – @GCI_Cluster  Instagram – @gynecancerinitiative  Facebook – facebook.com/gynecancerinitiative TikTok – @gci_gosh

    20 min

  5. MAR 2

    Prevention in Focus: Modifiable Risk Factors for Ovarian Cancer

    In this episode, Sabrina sits down with Dr. Jennifer Ritonja, a scientist in the Department of Population Health Sciences at the BC Cancer and epidemiologist specializing in modifiable risk factors for women’s cancers. Together, they explore what life-course research tells us about physical activity, body fatness, vitamin D, and the realistic potential of lifestyle-based prevention for ovarian cancer. Does timing matter? Is being active at one stage of adulthood enough? And how do we distinguish between what’s truly modifiable versus what’s simply associated? This conversation dives into the science behind prevention — and the methodological challenges of identifying meaningful risk factors across decades of life. 🎧 Listen now wherever you get your podcasts. #CancerEpidemiology #OvarianCancer #PreventionScience #WomensHealth #LifeCourseEpidemiology #PublicHealthResearch For more information on the Gynecologic Cancer Initiative, please visit https://gynecancerinitiative.ca/ or email us at info@gynecancerinitiative.ca  Where to learn more about us:   Twitter – @GCI_Cluster  Instagram – @gynecancerinitiative  Facebook – facebook.com/gynecancerinitiative TikTok – @gci_gosh

    16 min

  6. FEB 26

    Launching BEACON: a new research program to understand the role of contraceptive choice and ovarian cancer risk

    How does contraceptive choice influence ovarian cancer risk? On this episode of the GOSH Podcast, we discuss BEACON, a five-year CIHR-funded research program examining the biologic and population-level links between contraception and ovarian cancer prevention. We are joined by Dr. David Huntsman, Dr. Gillian Hanley, and Dr. Laura Schummers, stepping in for Aim 3 Lead Dr. Wendy Norman, to explore how this interdisciplinary team is integrating molecular pathology, epidemiology, and health policy to better understand how contraceptive decisions may shape ovarian cancer risk. Listen now at the link in our bio! For more information on the Gynecologic Cancer Initiative, please visit https://gynecancerinitiative.ca/ or email us at info@gynecancerinitiative.ca  Where to learn more about us:   Twitter – @GCI_Cluster  Instagram – @gynecancerinitiative  Facebook – facebook.com/gynecancerinitiative TikTok – @gci_gosh

    17 min

  7. FEB 16

    Next Gen in 10: Hormone Therapy and Cancer Risk in Real-World Data

    In this episode, we’re joined by Tessa Woodside, MSc student at UBC, whose research examines hormone therapy use and breast and endometrial cancer risk using large, real-world health data from BC and Alberta. Tessa walks us through her research questions, methods, early findings, and why the details of hormone therapy matter when we talk about cancer risk. 🎧 Tune in to hear how population-level data can answer questions clinical trials often can’t. For more information on the Gynecologic Cancer Initiative, please visit https://gynecancerinitiative.ca/ or email us at info@gynecancerinitiative.ca  Where to learn more about us:   Twitter – @GCI_Cluster  Instagram – @gynecancerinitiative  Facebook – facebook.com/gynecancerinitiative TikTok – @gci_gosh

    13 min

  8. FEB 2

    Rare but Urgent: Emerging Targets and Biomarkers in Vulvar Cancer

    New GOSH episode out now! 🎙️ On this episode, we are joined by Dr. Madeline Rhind, a medical oncology fellow at BC Cancer, to discuss her work on druggable targets and prognostic biomarkers in vulvar squamous cell carcinoma. The conversation highlights challenges in rare cancer research and the importance of translating molecular discoveries into clinical care. Tune in now at the link in our bio! #vulvarcancer #gynecancer #bccancer  For more information on the Gynecologic Cancer Initiative, please visit https://gynecancerinitiative.ca/ or email us at info@gynecancerinitiative.ca  Where to learn more about us:   Twitter – @GCI_Cluster  Instagram – @gynecancerinitiative  Facebook – facebook.com/gynecancerinitiative TikTok – @gci_gosh

    19 min
See All (78)

About

Presented by the Gynecologic Cancer Initiative, the Gynecologic Oncology Sharing Hub (GOSH) is an open space for real and evidence-based discussions on gynecologic cancers. We share stories of lived experiences alongside research and clinical discoveries through conversations that turn insights into impact.

Information

  • Creator
    Gynecologic Cancer Initiative
  • Years Active
    2020 - 2026
  • Episodes
    78
  • Rating
    Explicit
  • Copyright
    © 2026 GOSH Podcast
  • Show Website
    GOSH Podcast